ExploreWatchlistsPricing
  1. JP-listed companies
  2. ADR120S, Inc.
  3. Financials
  4. EBITDA

ADR120S, Inc. (3750)

Market cap
¥7.3B
P/E ratio
102.2x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 2025-757+34.19%
Mar 31, 2024-564+10.92%
Mar 31, 2023-509+171.78%
Mar 31, 2022-187-60.15%
Mar 31, 2021-470-2367.47%
Mar 31, 202021-93.96%
Mar 31, 2019343+145.21%
Mar 31, 2018140-135.90%
Mar 31, 2017-390+70.13%
Mar 31, 2016-229-148.42%
Mar 31, 2015473

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat